We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

60 hedge funds and large institutions have $553M invested in Foghorn Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

64% more capital invested

Capital invested by funds: $338M → $553M (+$215M)

28% more funds holding

Funds holding: 47 → 60 (+13)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.42% less ownership

Funds ownership: 65.73% → 65.31% (-0.42%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

73% less call options, than puts

Call options by funds: $949K | Put options by funds: $3.52M

Holders
60
Holders Change
+13
Holders Change %
+27.66%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
13
Reduced
16
Closed
7
Calls
$949K
Puts
$3.52M
Net Calls
-$2.57M
Net Calls Change
-$2.57M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.51M
2
EI
EAM Investors
California
+$2.15M
3
EGI
EAM Global Investors
California
+$1.48M
4
DCM
Driehaus Capital Management
Illinois
+$1.29M
5
State Street
State Street
Massachusetts
+$1.11M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$6.14M
2
MIM
Monashee Investment Management
Massachusetts
-$4.18M
3
CC
Casdin Capital
New York
-$3M
4
KCM
Kingdon Capital Management
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$290M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$56.8M -$507K -35,300 -1%
AG
3
Artal Group
Luxembourg
$39.4M – – –
EC
4
Euclidean Capital
New York
$28.8M – – –
BlackRock
5
BlackRock
New York
$26.3M +$407K +28,288 +3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$19.3M +$68.6K +4,774 +0.6%
Morgan Stanley
7
Morgan Stanley
New York
$12.6M -$6.14M -427,322 -44%
AI
8
Alphabet Inc
California
$11.5M – – –
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$8.77M +$5.51M +383,472 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$7.94M +$1.07M +74,688 +27%
BC
11
Birchview Capital
Vermont
$7.18M – – –
State Street
12
State Street
Massachusetts
$6.92M +$1.11M +77,554 +34%
MIM
13
Monashee Investment Management
Massachusetts
$5.49M -$4.18M -290,581 -55%
Northern Trust
14
Northern Trust
Illinois
$3.9M -$66.1K -4,596 -3%
EI
15
EAM Investors
California
$3.41M +$2.15M +149,280 New
Millennium Management
16
Millennium Management
New York
$3.14M +$640K +44,541 +48%
EGI
17
EAM Global Investors
California
$2.36M +$1.48M +103,241 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$2.32M +$695K +48,321 +91%
DCM
19
Driehaus Capital Management
Illinois
$2.06M +$1.29M +90,000 New
PPA
20
Parametric Portfolio Associates
Washington
$1.43M +$901K +62,663 New
KCM
21
Kingdon Capital Management
New York
$1.24M -$2.18M -151,400 -74%
Charles Schwab
22
Charles Schwab
California
$1.16M +$12.3K +853 +2%
Jane Street
23
Jane Street
New York
$1.07M +$670K +46,638 New
BBA
24
Baker Bros. Advisors
New York
$1.03M +$647K +45,027 New
SEI Investments
25
SEI Investments
Pennsylvania
$880K +$553K +38,464 New
1
2 3

FHTX Hedge Fund Activity: Q4 2021 in Review

60 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2021, worth a combined $553M — up 64% from $338M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FHTX positions and 7 closed out — a net gain of 13 holders — while 13 added to existing stakes and 16 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.51M. The largest seller was Morgan Stanley, cutting an estimated $6.14M.

  • 60 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2021, up from 47 in Q3 2021.
  • Funds reported $553M of Foghorn Therapeutics stock for Q4 2021, up 64% quarter-over-quarter.
  • 20 funds opened new Foghorn Therapeutics positions in Q4 2021 and 7 closed out, a net change of +13 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2021 was Point72 Asset Management, an estimated $5.51M added.
  • The largest Foghorn Therapeutics seller in Q4 2021 was Morgan Stanley, an estimated $6.14M sold.

Based on aggregated 13F filings for Q4 2021.